FUS, another significant pathological aspect of ALS, has also been demonstrated to disrupt the association between VAPB and PTPIP51, as well as the tethering of MAMs, via the activation of GSK‐3β [167]. This evidence concerns the gene RMDN3 and amyotrophic lateral sclerosis.